TABLE 3.

Characteristics of FMT Given in IBD Patients

	FMT for C. difficile (N = 22) n (%)	FMT for Other Indication (N = 29) n (%)	P
Number of antibiotic courses for C. difficile before FMT  2  3–4  ≥5	7 (31.8) 9 (40.9) 6 (27.3)	—	0.691
Duration since last FMT  Within 1 year  More than 1 year ago	5 (22.7) 17 (77.3)	5 (17.2) 24 (82.8)	0.685
Route of FMT  Nasogastric tube  Colonoscopy  Enema  Pill/capsule  Self-administration	4 (18.2) 15 (68.2) 0 (0) 2 (9.1) 1 (4.5)	0 (0) 2 (6.9) 5 (17.2) 1 (3.4) 21 (72.4)	<0.001
Source of FMT  Known donor/family member  Commercial source  Hospital or clinic source	12 (54.5) 4 (18.2) 6 (27.3)	25 (86.2) 0 (0) 4 (13.8)	0.017
FMT as part of a research study	4 (18.2)	3 (10.3)	0.032
Provider directing FMT treatment  Primary care provider  Gastroenterologist  Other physician  Other health care provider  Self  Other	1 (4.5) 11 (50.0) 7 (31.8) 1 (4.5) 1 (4.5) 1 (4.5)	1 (3.4) 2 (6.9) 3 (10.3) 3 (10.3) 20 (69.0) 0 (0.0)	<0.001